GH-axis research
Ipamorelin
Peptídeo liofilizado de pesquisa de sinalização endócrina para revisão de sistemas
Ipamorelin is a selective growth hormone secretagogue receptor research peptide used in GH-release and endocrine-signaling comparisons.
This product has an available COA with reported batch details and test results.
Open available COAConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesSomente para uso em pesquisa laboratorial. Não é para uso humano ou veterinário. Não se destina a diagnosticar, tratar, curar, mitigar ou prevenir doenças.
Mantenha selado, frio, seco e protegido de oscilações de calor. Confirme o armazenamento específico do produto na chegada.
Embalado para estabilidade de trânsito com suporte para pedidos disponível para rotas em clima quente.
Batch-linked certificate support is available through the documentation desk.
Contexto de pesquisa
Perfil de pesquisa de Ipamorelin
Ipamorelin is a pentapeptide growth hormone secretagogue studied for activity at the ghrelin receptor, also known as GHS-R1a. Experimental work compares GH-release response, pharmacokinetics, receptor selectivity, and effects on other endocrine markers with older secretagogues such as GHRP-2, GHRP-6, and hexarelin. It differs from CJC-1295 and sermorelin because those compounds act through the GHRH receptor rather than GHS-R. Ipamorelin is therefore a focused choice for secretagogue and receptor-selectivity studies, either alone or as a comparator in GH-axis designs. Early human PK/PD literature exists, but it does not validate a research-use catalog lot.
Molecular class
Five-residue ghrelin-receptor secretagogue
Sequence / composition
Aib-His-D-2-Nal-D-Phe-Lys-NH2; a short sequence containing non-proteinogenic and D-amino-acid residues.
Research design note
The stereochemical substitutions are part of the construct and should be preserved in identity testing.
Mecanismo proposto
A pentapeptide agonist at the growth-hormone secretagogue receptor GHS-R1a. Receptor activation engages Gq-related signaling in pituitary and hypothalamic systems and stimulates growth-hormone release.
Efeitos relatados em estudos
- Animal and human pharmacology studies reported dose-dependent GH release after ipamorelin exposure.
- Comparative studies described greater GH selectivity and less ACTH or cortisol stimulation than some older GHRP compounds under studied conditions.
- It remains a ghrelin-receptor agonist, and selectivity does not mean absence of all off-target or systemic effects.
Desfechos comuns de pesquisa
GHS-R1a potency, calcium or second-messenger response, GH concentration and pulse shape, ACTH, cortisol, prolactin, appetite markers, pharmacokinetics, and desensitization.
Evidências e limitações
Preclinical and early controlled human PK/PD evidence exists. Long-term human outcomes and equivalence of catalog material are not established.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
Where can I find product documentation?
Open the direct COA link on this page. For other batch documents, contact support with the product name and any relevant order or batch reference.
How can I compare pack options?
Where multiple pack sizes are available, Azure shows the price per listed vial so you can compare catalog value directly.